Next&Bio Inc. has signed a memorandum of understanding (MOU) with the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore on the establishment of collaboration to realize the development of novel precision medicine therapeutics using cancer-organoids.
[Next&Bio Inc. (Business Wire)]